<img src="https://ml.globenewswire.com/Resource/Download/8a986b0a-11c8-4551-b0ad-ec20fe2fe40a?size=2" nborder="0" align="left" hspace="5" vspace="5" title="Relmada logo.png" alt="Relmada Therapeutics"/>CORAL GABLES, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced plans to host a conference call and webcast on Thursday, August 6, 2026 at 4:30 PM ET to discuss financial results for the second quarter ended June 30, 2026, and recent business progress. Conference Call and Webcast Information: <ul type="disc"><li style="text-align:justify;">Date: Thursday, August 6, 2026 at 4:30 PM ET</li><li style="text-align:justify;">Participant Dial-in (US): 1-800-717-1738</li><li style="text-align:justify;">Participant Dial-in (International): 1-646-307-1865</li><li style="text-align:justify;">Webcast Access: <a href="https://www.globenewswire.com/Tracker?data=6kJVVSLzJa08sOOm0a2-8AZemVkmrzeyeFOdh1GZW1zcjBfpn3Ate40I5feJdpptJFd7S84wwsFsnHTNy8ID_pVw3K--28vf4YtLw2Q5iOyFh_5WUF_-kjFT1IjSTCDEc3uMKvbg4VbCtabnvyU5Ug==" rel="nofollow" target="_blank" title="Click Here">Click Here</a></li></ul> A replay of the webcast will be available in the Investors section of the Relmada website at <a href="https://www.globenewswire.com/Tracker?data=E_Yn9qqhJ0wOwa8G9AP1Jzp7YYHXpshk41sj81OnQp8JKw0er5WjhvE14ARg3s-kR5cdGSNvgBqKaxizx1XdpZDPd2zovg0et1iGgcW8zfcEd9shYbXBeat6AOGTiqsbrhqojdUBdK6Xqqj1HGXAwt32Fp-0VKuPGaJp-b6tCCA=" rel="nofollow" target="_blank" title="">https://www.relmada.com/investors/ir-calendar</a>. About Relmada Therapeutics, Inc. Relmada Therapeutics is a clinical-stage biotechnology company focused on developing transformative therapies for oncology and central nervous system conditions. Its lead candidates, NDV-01 and sepranolone, are advancing through mid-stage clinical development with the potential to address significant unmet needs. For more information, visit <a href="https://www.globenewswire.com/Tracker?data=_aW1q1GT-iYEMfNWoMfNQUcDc5AcUqR-9EW-r9OmYI0UHFYebey9Ekl3qp968EWYH-53FEHe6Iys1dWbPiXlpE6ieo0dtRH4yd1V7K46uy0=" rel="nofollow" target="_blank" title="">www.relmada.com</a> Investor Contact: Brian Ritchie LifeSci Advisors <a href="https://www.globenewswire.com/Tracker?data=u0VssqvwGfY3vBRxGxivJDyQVIB2Hnp5FP66BC7BzJjGvc3yQpkhZWafudVfNu_CrQr-KhuXkPC2S_B69SC1cFMVqS_sAxa5y8jYIA6aiHIVhcVo_SPSfwz1kP07wf7X" rel="nofollow" target="_blank" title="britchie@lifesciadvisors.com">britchie@lifesciadvisors.com</a> Media Inquiries: Corporate Communications <a href="https://www.globenewswire.com/Tracker?data=FSq1w0GYN05MuqvdNizru4E_7p5uJNIZNcjTjRKL5HFfp9tAg8sH6DAP5mvSHqy3mLA42TPMLMBVJtyrhh4kE3YGQlyJ0Dytz2iJ2d-odCw=" rel="nofollow" target="_blank" title="media@relmada.com">media@relmada.com</a> <img alt="" src='https://ml.globenewswire.com/media/MDkxNDFjYTktZjgxNC00MjNiLThkMTUtMGY2ZTAzMmFiOTRiLTUwMDA5Nzc1My0yMDI2LTA3LTE2LWVu/tiny/Relmada-Therapeutics.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn